Industry Research Reports

Home > Reports > Medical Care > Global Biological Indicators Market Research Report 2026

Global Biological Indicators Market Research Report 2026

Industry: Medical Care

Published Date: 2026-01-04

Pages: 117 Pages

Report ld: 5534428

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Biological Indicators Market Size(US$)

CAGR 2026-2032

5.9%

Market Size,2032

USD 643

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 456 million

Market Forecast in 2032(Value)

US$ 643 million

CAGR

5.9%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Biological Indicators market was valued at US$ 433 million in 2025 and is anticipated to reach US$ 643 million by 2032, at a CAGR of 5.9% from 2026 to 2032.

Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.

Biological Indicators (BIs) play a critical role in sterilization validation and infection control, widely used in medical devices, pharmaceuticals, food processing, and life sciences laboratories. They assess the effectiveness of steam, dry heat, ethylene oxide (EO), hydrogen peroxide, and other sterilization methods, ensuring compliance with ISO 11138, USP, and FDA regulations.

Based on form factor, BIs can be categorized into Self-Contained Biological Indicators (SCBIs), BI Strips, and BI Suspensions. Among them, SCBIs are widely used due to their convenience, reduced contamination risk, and enhanced validation efficiency.

In terms of application, the medical sector dominates the market, as hospitals and medical device manufacturers must routinely validate sterilization equipment like autoclaves and plasma sterilizers. The pharmaceutical industry also has stringent requirements for sterilization, especially in injectable drugs, vaccines, and sterile drug production. Additionally, the food and beverage sector is increasingly adopting BIs to monitor sterilization efficiency in processing equipment, ensuring food safety and regulatory compliance.

Regionally, North America is the largest market, with a share nearly 55%. North America and Europe lead the market due to stringent medical regulations and high industry standards. The Asia-Pacific region (especially China and India) is experiencing rapid growth in the BI market, driven by expanding healthcare and pharmaceutical industries and evolving regulatory frameworks. Latin America and the Middle East are also emerging markets, benefiting from improvements in healthcare infrastructure.

Looking ahead, the BI industry is shifting toward more efficient, intelligent, and automated solutions. Rapid-read BIs, electronic BIs (E-BIs), and smart monitoring systems are gradually replacing traditional methods, reducing manual intervention, accelerating sterilization validation, and improving quality control. As pharmaceutical regulations tighten and medical device standards advance, the demand for BIs is expected to rise, ensuring a more reliable approach to sterilization validation and infection control worldwide.

This report delivers a comprehensive overview of the global Biological Indicators market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biological Indicators. The Biological Indicators market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Biological Indicators market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Biological Indicators manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

3M
Getinge Group
Cantel Medical
Mesa Laboratories
Steris
Fuze Medical
Matachana
Hu-Friedy
Advanced Sterilization
Bag Health Care
Terragene
Andersen
GKE

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Self-Contained Biological Indicator
Biological Indicator Strip
Others

Segment by Application

Hospital
Pharma Companies
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Biological Indicators companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biological Indicators Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Self-Contained Biological Indicator

1.2.3 Biological Indicator Strip

1.2.4 Others

1.3 Market by Application

1.3.1 Global Biological Indicators Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Pharma Companies

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biological Indicators Market Perspective (2021–2032)

2.2 Global Biological Indicators Growth Trends by Region

2.2.1 Global Biological Indicators Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Biological Indicators Historic Market Size by Region (2021–2026)

2.2.3 Biological Indicators Forecasted Market Size by Region (2027–2032)

2.3 Biological Indicators Market Dynamics

2.3.1 Biological Indicators Industry Trends

2.3.2 Biological Indicators Market Drivers

2.3.3 Biological Indicators Market Challenges

2.3.4 Biological Indicators Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biological Indicators Players by Revenue

3.1.1 Global Top Biological Indicators Players by Revenue (2021–2026)

3.1.2 Global Biological Indicators Revenue Market Share by Players (2021–2026)

3.2 Global Top Biological Indicators Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Biological Indicators Revenue

3.4 Global Biological Indicators Market Concentration Ratio

3.4.1 Global Biological Indicators Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biological Indicators Revenue in 2025

3.5 Global Key Players of Biological Indicators Head Offices and Areas Served

3.6 Global Key Players of Biological Indicators, Products and Applications

3.7 Global Key Players of Biological Indicators, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Biological Indicators Breakdown Data by Type

4.1 Global Biological Indicators Historic Market Size by Type (2021–2026)

4.2 Global Biological Indicators Forecasted Market Size by Type (2027–2032)

5 Biological Indicators Breakdown Data by Application

5.1 Global Biological Indicators Historic Market Size by Application (2021–2026)

5.2 Global Biological Indicators Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Biological Indicators Market Size (2021–2032)

6.2 North America Biological Indicators Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Biological Indicators Market Size by Country (2021–2026)

6.4 North America Biological Indicators Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biological Indicators Market Size (2021–2032)

7.2 Europe Biological Indicators Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Biological Indicators Market Size by Country (2021–2026)

7.4 Europe Biological Indicators Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Biological Indicators Market Size (2021–2032)

8.2 Asia-Pacific Biological Indicators Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Biological Indicators Market Size by Region (2021–2026)

8.4 Asia-Pacific Biological Indicators Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Biological Indicators Market Size (2021–2032)

9.2 Latin America Biological Indicators Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Biological Indicators Market Size by Country (2021–2026)

9.4 Latin America Biological Indicators Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biological Indicators Market Size (2021–2032)

10.2 Middle East & Africa Biological Indicators Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Biological Indicators Market Size by Country (2021–2026)

10.4 Middle East & Africa Biological Indicators Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 3M

11.1.1 3M Company Details

11.1.2 3M Business Overview

11.1.3 3M Biological Indicators Introduction

11.1.4 3M Revenue in Biological Indicators Business (2021–2026)

11.1.5 3M Recent Development

11.2 Getinge Group

11.2.1 Getinge Group Company Details

11.2.2 Getinge Group Business Overview

11.2.3 Getinge Group Biological Indicators Introduction

11.2.4 Getinge Group Revenue in Biological Indicators Business (2021–2026)

11.2.5 Getinge Group Recent Development

11.3 Cantel Medical

11.3.1 Cantel Medical Company Details

11.3.2 Cantel Medical Business Overview

11.3.3 Cantel Medical Biological Indicators Introduction

11.3.4 Cantel Medical Revenue in Biological Indicators Business (2021–2026)

11.3.5 Cantel Medical Recent Development

11.4 Mesa Laboratories

11.4.1 Mesa Laboratories Company Details

11.4.2 Mesa Laboratories Business Overview

11.4.3 Mesa Laboratories Biological Indicators Introduction

11.4.4 Mesa Laboratories Revenue in Biological Indicators Business (2021–2026)

11.4.5 Mesa Laboratories Recent Development

11.5 Steris

11.5.1 Steris Company Details

11.5.2 Steris Business Overview

11.5.3 Steris Biological Indicators Introduction

11.5.4 Steris Revenue in Biological Indicators Business (2021–2026)

11.5.5 Steris Recent Development

11.6 Fuze Medical

11.6.1 Fuze Medical Company Details

11.6.2 Fuze Medical Business Overview

11.6.3 Fuze Medical Biological Indicators Introduction

11.6.4 Fuze Medical Revenue in Biological Indicators Business (2021–2026)

11.6.5 Fuze Medical Recent Development

11.7 Matachana

11.7.1 Matachana Company Details

11.7.2 Matachana Business Overview

11.7.3 Matachana Biological Indicators Introduction

11.7.4 Matachana Revenue in Biological Indicators Business (2021–2026)

11.7.5 Matachana Recent Development

11.8 Hu-Friedy

11.8.1 Hu-Friedy Company Details

11.8.2 Hu-Friedy Business Overview

11.8.3 Hu-Friedy Biological Indicators Introduction

11.8.4 Hu-Friedy Revenue in Biological Indicators Business (2021–2026)

11.8.5 Hu-Friedy Recent Development

11.9 Advanced Sterilization

11.9.1 Advanced Sterilization Company Details

11.9.2 Advanced Sterilization Business Overview

11.9.3 Advanced Sterilization Biological Indicators Introduction

11.9.4 Advanced Sterilization Revenue in Biological Indicators Business (2021–2026)

11.9.5 Advanced Sterilization Recent Development

11.10 Bag Health Care

11.10.1 Bag Health Care Company Details

11.10.2 Bag Health Care Business Overview

11.10.3 Bag Health Care Biological Indicators Introduction

11.10.4 Bag Health Care Revenue in Biological Indicators Business (2021–2026)

11.10.5 Bag Health Care Recent Development

11.11 Terragene

11.11.1 Terragene Company Details

11.11.2 Terragene Business Overview

11.11.3 Terragene Biological Indicators Introduction

11.11.4 Terragene Revenue in Biological Indicators Business (2021–2026)

11.11.5 Terragene Recent Development

11.12 Andersen

11.12.1 Andersen Company Details

11.12.2 Andersen Business Overview

11.12.3 Andersen Biological Indicators Introduction

11.12.4 Andersen Revenue in Biological Indicators Business (2021–2026)

11.12.5 Andersen Recent Development

11.13 GKE

11.13.1 GKE Company Details

11.13.2 GKE Business Overview

11.13.3 GKE Biological Indicators Introduction

11.13.4 GKE Revenue in Biological Indicators Business (2021–2026)

11.13.5 GKE Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Biological Indicators Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Self-Contained Biological Indicator

Table 3. Key Players of Biological Indicator Strip

Table 4. Key Players of Others

Table 5. Global Biological Indicators Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Biological Indicators Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Biological Indicators Market Size by Region (US$ Million), 2021–2026

Table 8. Global Biological Indicators Market Share by Region (2021–2026)

Table 9. Global Biological Indicators Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Biological Indicators Market Share by Region (2027–2032)

Table 11. Biological Indicators Market Trends

Table 12. Biological Indicators Market Drivers

Table 13. Biological Indicators Market Challenges

Table 14. Biological Indicators Market Restraints

Table 15. Global Biological Indicators Revenue by Players (US$ Million), 2021–2026

Table 16. Global Biological Indicators Market Share by Players (2021–2026)

Table 17. Global Top Biological Indicators Players by Tier (Tier 1, Tier 2, and Tier 3), based on Biological Indicators Revenue, 2025

Table 18. Ranking of Global Top Biological Indicators Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Biological Indicators Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Biological Indicators, Headquarters and Area Served

Table 21. Global Key Players of Biological Indicators, Products and Applications

Table 22. Global Key Players of Biological Indicators, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Biological Indicators Market Size by Type (US$ Million), 2021–2026

Table 25. Global Biological Indicators Revenue Market Share by Type (2021–2026)

Table 26. Global Biological Indicators Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Biological Indicators Revenue Market Share by Type (2027–2032)

Table 28. Global Biological Indicators Market Size by Application (US$ Million), 2021–2026

Table 29. Global Biological Indicators Revenue Market Share by Application (2021–2026)

Table 30. Global Biological Indicators Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Biological Indicators Revenue Market Share by Application (2027–2032)

Table 32. North America Biological Indicators Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Biological Indicators Market Size by Country (US$ Million), 2021–2026

Table 34. North America Biological Indicators Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Biological Indicators Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Biological Indicators Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Biological Indicators Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Biological Indicators Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Biological Indicators Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Biological Indicators Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Biological Indicators Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Biological Indicators Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Biological Indicators Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Biological Indicators Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Biological Indicators Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Biological Indicators Market Size by Country (US$ Million), 2027–2032

Table 47. 3M Company Details

Table 48. 3M Business Overview

Table 49. 3M Biological Indicators Product

Table 50. 3M Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 51. 3M Recent Development

Table 52. Getinge Group Company Details

Table 53. Getinge Group Business Overview

Table 54. Getinge Group Biological Indicators Product

Table 55. Getinge Group Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 56. Getinge Group Recent Development

Table 57. Cantel Medical Company Details

Table 58. Cantel Medical Business Overview

Table 59. Cantel Medical Biological Indicators Product

Table 60. Cantel Medical Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 61. Cantel Medical Recent Development

Table 62. Mesa Laboratories Company Details

Table 63. Mesa Laboratories Business Overview

Table 64. Mesa Laboratories Biological Indicators Product

Table 65. Mesa Laboratories Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 66. Mesa Laboratories Recent Development

Table 67. Steris Company Details

Table 68. Steris Business Overview

Table 69. Steris Biological Indicators Product

Table 70. Steris Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 71. Steris Recent Development

Table 72. Fuze Medical Company Details

Table 73. Fuze Medical Business Overview

Table 74. Fuze Medical Biological Indicators Product

Table 75. Fuze Medical Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 76. Fuze Medical Recent Development

Table 77. Matachana Company Details

Table 78. Matachana Business Overview

Table 79. Matachana Biological Indicators Product

Table 80. Matachana Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 81. Matachana Recent Development

Table 82. Hu-Friedy Company Details

Table 83. Hu-Friedy Business Overview

Table 84. Hu-Friedy Biological Indicators Product

Table 85. Hu-Friedy Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 86. Hu-Friedy Recent Development

Table 87. Advanced Sterilization Company Details

Table 88. Advanced Sterilization Business Overview

Table 89. Advanced Sterilization Biological Indicators Product

Table 90. Advanced Sterilization Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 91. Advanced Sterilization Recent Development

Table 92. Bag Health Care Company Details

Table 93. Bag Health Care Business Overview

Table 94. Bag Health Care Biological Indicators Product

Table 95. Bag Health Care Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 96. Bag Health Care Recent Development

Table 97. Terragene Company Details

Table 98. Terragene Business Overview

Table 99. Terragene Biological Indicators Product

Table 100. Terragene Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 101. Terragene Recent Development

Table 102. Andersen Company Details

Table 103. Andersen Business Overview

Table 104. Andersen Biological Indicators Product

Table 105. Andersen Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 106. Andersen Recent Development

Table 107. GKE Company Details

Table 108. GKE Business Overview

Table 109. GKE Biological Indicators Product

Table 110. GKE Revenue in Biological Indicators Business (US$ Million), 2021–2026

Table 111. GKE Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Biological Indicators Picture

Figure 2. Global Biological Indicators Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Biological Indicators Market Share by Type: 2025 vs 2032

Figure 4. Self-Contained Biological Indicator Features

Figure 5. Biological Indicator Strip Features

Figure 6. Others Features

Figure 7. Global Biological Indicators Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Biological Indicators Market Share by Application: 2025 vs 2032

Figure 9. Hospital Case Studies

Figure 10. Pharma Companies Case Studies

Figure 11. Others Case Studies

Figure 12. Biological Indicators Report Years Considered

Figure 13. Global Biological Indicators Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Biological Indicators Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Biological Indicators Market Share by Region: 2025 vs 2032

Figure 16. Global Biological Indicators Market Share by Players in 2025

Figure 17. Global Biological Indicators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Biological Indicators Revenue in 2025

Figure 19. North America Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Biological Indicators Market Share by Country (2021–2032)

Figure 21. United States Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Biological Indicators Market Share by Country (2021–2032)

Figure 25. Germany Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Biological Indicators Market Share by Region (2021–2032)

Figure 33. China Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Biological Indicators Market Share by Country (2021–2032)

Figure 41. Mexico Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Biological Indicators Market Share by Country (2021–2032)

Figure 45. Israel Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Biological Indicators Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. 3M Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 49. Getinge Group Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 50. Cantel Medical Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 51. Mesa Laboratories Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 52. Steris Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 53. Fuze Medical Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 54. Matachana Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 55. Hu-Friedy Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 56. Advanced Sterilization Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 57. Bag Health Care Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 58. Terragene Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 59. Andersen Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 60. GKE Revenue Growth Rate in Biological Indicators Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Biological Indicators in 2032? zhanKai

The global market size of Biological Indicators in 2032 was 643 Million USD.

Which companies rank high in the global Biological Indicators market? shouQi

What was the global market size of Biological Indicators in 2026? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Biological Indicators market size from 2026 to 2032? shouQi

Related Reports

Global Biological Indicators Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Biological Indicators market size was US$ 433 million in 2025 and is forecast to reach a readjusted size of US$ 643 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 93
USD 4250.00
(Single User License)
Biological Indicators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biological Indicators was estimated to be worth US$ 433 million in 2025 and is projected to reach US$ 643 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 3950.00
(Single User License)
Biological Indicators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biological Indicators was estimated to be worth US$ 411 million in 2024 and is forecast to a readjusted size of US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-11-03
Pages: 115
USD 3950.00
(Single User License)
Global Biological Indicators Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Biological Indicators market is projected to grow from US$ 411 million in 2024 to US$ 610 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 136
USD 4900.00
(Single User License)
Global Biological Indicators Market Insights, Forecast to 2031
The global Biological Indicators market is projected to grow from US$ 433 million in 2025 to US$ 610 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.
Published Date: 2025-03-28
Pages: 143
USD 4900.00
(Single User License)
Global Biological Indicators Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biological Indicators market size was US$ 411 million in 2024 and is forecast to a readjusted size of US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 98
USD 4250.00
(Single User License)
Global Biological Indicators Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Biological Indicators was estimated to be worth US$ 411 million and is forecast to reach approximately US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 132
USD 5900.00
(Single User License)
Global Biological Indicators Market Research Report 2025
The global market for Biological Indicators was valued at US$ 411 million in the year 2024 and is projected to reach a revised size of US$ 610 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-03-28
Pages: 86
USD 2900.00
(Single User License)
Biological Indicators- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biological Indicators was estimated to be worth US$ 411 million in 2024 and is forecast to a readjusted size of US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 101
USD 3950.00
(Single User License)
Global Biological Indicators Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Published Date: 2024-04-17
Pages: 154
USD 5600.00
(Single User License)

Global Biological Indicators Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Biological Indicators market size was US$ 433 million in 2025 and is forecast to reach a readjusted size of US$ 643 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 93
USD 4250.00 (Single User License)
Biological Indicators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biological Indicators was estimated to be worth US$ 433 million in 2025 and is projected to reach US$ 643 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
USD 3950.00 (Single User License)
Biological Indicators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biological Indicators was estimated to be worth US$ 411 million in 2024 and is forecast to a readjusted size of US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-11-03
Pages: 115
USD 3950.00 (Single User License)
Global Biological Indicators Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Biological Indicators market is projected to grow from US$ 411 million in 2024 to US$ 610 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 136
USD 4900.00 (Single User License)
Global Biological Indicators Market Insights, Forecast to 2031
The global Biological Indicators market is projected to grow from US$ 433 million in 2025 to US$ 610 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.
Published: 2025-03-28
Pages: 143
USD 4900.00 (Single User License)
Global Biological Indicators Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biological Indicators market size was US$ 411 million in 2024 and is forecast to a readjusted size of US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 98
USD 4250.00 (Single User License)
Global Biological Indicators Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Biological Indicators was estimated to be worth US$ 411 million and is forecast to reach approximately US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 132
USD 5900.00 (Single User License)
Global Biological Indicators Market Research Report 2025
The global market for Biological Indicators was valued at US$ 411 million in the year 2024 and is projected to reach a revised size of US$ 610 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-03-28
Pages: 86
USD 2900.00 (Single User License)
Biological Indicators- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biological Indicators was estimated to be worth US$ 411 million in 2024 and is forecast to a readjusted size of US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 101
USD 3950.00 (Single User License)
Global Biological Indicators Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Published: 2024-04-17
Pages: 154
USD 5600.00 (Single User License)